Právní předpis byl sestaven k datu 08.03.2018.
Zobrazené znění právního předpisu je účinné od 08.03.2018 do 24.10.2018.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
463
XXXXXXXX XXXXX
xx xxx 18. prosince 2013
o xxxxxxxxx návykových xxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 xxxxxx x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x x xxxxx xxxxxxxxx xxxxxxx zákonů, xx xxxxx xxxxxx x. 273/2013 Xx.:
§1
Toto xxxxxxxx xxxxxxx
x) x příloze č. 1 x xxxxxx nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxxxx úmluvy x omamných látkách1) x
2. dalších xxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx z xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx tyto xxxxxx xxxxx byly vydávány x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx z xxxxxx dolního xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx jen "xxxxxx x. 1 omamných xxxxx"),
x) x příloze č. 2 x tomuto nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx XX podle Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx vydávány v xxxxxxx xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "seznam x. 2 omamných xxxxx"),
x) x příloze č. 3 k xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx proto, že xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x povolení x xxxxxxxxx,
(xxxx xxx "xxxxxx x. 3 xxxxxxxx látek"),
d) v příloze č. 4 x tomuto xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx X podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx proto, xx bezprostředně xxxx xxxxxxx ohrožují xxxxxx, xxxxx zabezpečit, xxx xxxxx x xxxxxxxxx xxxxxxxxxx tyto xxxxxxxxxxxx xxxxx xxxx xxxxxxxxx xxxxx k xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx k xxxxxxxxx,
(xxxx xxx "xxxxxx x. 4 psychotropních látek"),
e) x příloze č. 5 x xxxxxx nařízení seznam
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx psychotropních látek, x xxxxx je x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx xxx xx xxxxxxx povolení x xxxxxxxxx, xxxx xx x xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx psychotropní látky xxxx xxxxxxxx x xxxxxxx xxxxx na xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx pruhem xxxxxxxxxx z levého xxxxxxx xxxx do xxxxxxx horního rohu,
(dále xxx "seznam x. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Úmluvy x xxxxxxxxxxxxxx xxxxxxx,
x) x příloze č. 7 x xxxxxx xxxxxxxx seznam
1. psychotropních xxxxx xxxxxxxxxx xx Xxxxxxx IV podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx bezprostředně nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxxx přípravky obsahující xxxx xxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxx nebo xxxxxxx xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "xxxxxx x. 7 xxxxxxxxxxxxxx látek"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx seznam xxxxxxxxx xxxxxxxxxx do Xxxxxxx III podle Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx jen "xxxxxx č. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx 98/34/ES ze xxx 22. xxxxxx 1998 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx xxxxx.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx Evropské xxxx xxxxxxxx xx xxxxxxxxxx látek3).
§3
Xxxx nařízení nabývá xxxxxxxxx xxxx 1. xxxxx 2014.
Příloha x. 1 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
Xxxxxxxxxxx nechráněný název (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx- 6,14-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
Xxxxxxx |
xxxxxxxx (1X,2X,3X,5X)-3-xxxxxxx-8-xxxxxx-9-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x deriváty, x kterých je xxxxx xxxxxx xxxxxxx x kokain |
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
Etonitazen |
1-[2-(deethylamino)ethyl]-2-(4-ethoxybenzyl]-5-nitro-1H-benzimidazol |
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
Fenadaxon |
4,4-difenyl-6-morfolinoheptan-3-on |
|
Fenampromid |
N-(1-methyl-2-piperidinoethyl)propananilid |
|
Fenazocin |
(2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano- 3-xxxxxxxxxx-8-xx |
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) xxxxx]xxx}xxxxxx |
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- karboxylát |
|
Koncentrát x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx xxxxxxxxx získaný xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxx x tinktura |
Extrakt x xxxxxxxx x xxxxxx |
|
Xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxx určené x xxxxxxxx xxxxxxxx přípravků xx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] je vyňat xx xxxxxxx xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] je xxxxx xx seznamu xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
Xxxxxxx, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxx methobromid |
4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid |
a jiné xxxxxxxx xxxxxxx xx xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx morfin-N-oxidu (x xxxxxx-X-xxxxx) |
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xxxxxx xxxxxx xx xxxxx než D4 xxxx CH2 |
|
Oripavin |
4,5α-epoxy-6-methoxy-17-methylmorfina-6,8(14)-dien-3-ol |
|
Oxykodon |
(5R)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorfinan-6-on |
|
Oxymorfon |
(5R)-4,5-epoxy-3,14-dihydroxy-17-methylmorfinan-6-on |
|
Parafluorfentanyl |
N-(1-fenethyIpiperidin-4-yl)-4'-fluorpropanamilid |
|
Pheneridin |
ethyl-1-fenethyl-4-fenylpiperidin-4-karboxylát |
PEPAP |
Pethidin |
ethyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
Pethidin, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx xxxxxx x xxxxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx x xxxx xxxxxxxx látek xxxxxxxxx x tomto xxxxxxx xxxxxx xxxx xxxxxxx, esterů a xxxxx ve xxxxx xxxxxxxxx, xxx tyto xxxx mohou existovat.
Xxxxxxx x. 2 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 2 omamných xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx izomerů xxxxxxxx xxxxx xxxxxxxxx v xxxxx seznamu, xxxx xxxx omamných xxxxx xxxxxxxxx v tomto xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu xx všech případech, xxx tyto xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 3 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 3 xxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx | |
Xxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx | |
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-methyl-6,14-ethenomorfinan-3-ol |
|
Heroin |
(5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát |
|
Ketobemidon |
1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on |
|
Konopí |
S xxxxxxxx xxxxxx pro xxxxxxx xxxxxxx xxxxxxx x xxxxxxx x. 1 |
|
Xxxxxxxxxx x konopí |
Včetně xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx případech, xxx tyto soli xxxxx existovat.
Příloha x. 4 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx / obecný xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
Xxxxxxxxxx |
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx |
||
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXXXXXXX |
XXX-XXX |
Xxxxxx 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
XXX-XXXXXX |
Xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
XXXXX |
XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Xxxxx-27 |
|
25X-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
X1 |
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
XXXXX-4XX-XXXXXX |
XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
Xxxxxxxxxxxx-2-xxxxx fentanyl |
N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin |
||
Despropionyl-4-fluor fentanyl |
N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin |
||
Dibutylon |
Bk-DMBDB |
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon |
Methylbutylon |
Diclazepam |
2-chlorodiazepam |
7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
Ro 5-3448 |
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
2,3-Xxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(2,3-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2,4-Xxxxxxxxxxxxxxxxxxx |
2,4-XXXX |
1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x][1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
XXX-XXX |
(6xX,9X)-X,X-xxxxxxx-7-xxxxx-4,6,6x,7,8,9-xxxxxxxxxxxxxx-[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
Xxxxxxxx |
XXX 3219; Depas |
4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin |
|
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
2-Ethylmethkathinon |
2-EMC |
(RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on |
|
3-Ethylmethkathinon |
3-EMC |
(RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on |
|
4-Ethylmethkathinon |
4-EMC |
(RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on |
|
Etryptamin |
3-(2-aminobutyl)indol |
||
2-Fluoramfetamin |
2-FA |
1-(2-fluorfenyl)propan-2-amin |
|
3-Fluoramfetamin |
3-FA |
1-(3-fluorfenyl)propan-2-amin |
|
4-Fluoramfetamin |
4-FA |
1-(4-fluorfenyl)propan-2-amin |
|
5F-ADBICA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
5F-AKB48 |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
||
5F-AMB-PINACA |
5F-AMB |
Methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát |
5F-AMP |
Fentanyl xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, m-FF |
4-Fluorisobutyrfentanyl |
4F-iBF |
N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
2-Fluormethamfetamin |
2-FMA |
(RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin |
|
3-Fluormethamfetamin |
3-FMA |
(RS)-1-(3-fluorfenyl)-N-methylpropan-2-amin |
|
4-Fluormethamfetamin |
4-FMA |
(RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin |
|
2-Fluormethkathinon |
2-FMC |
1-(2-fluorfenyl)-2-(methylamino)propan-1-on |
|
3-Fluormethkathinon |
3-FMC |
1-(3-fluorfenyl)-2-(methylamino)propan-1-on |
|
4-Fluormethkathinon |
4-FMC |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
Flefedron |
4-Fluormethylfenidát |
4F-MPH; 4-XXXX |
Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxxx)xxxxxx |
4X-XXX |
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
Xxxxxxxxxxxxxxx |
XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx |
2-xxxxxxxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxx xxxxxxxxx |
4-XX-XXX |
3-{2-[xxxxx(xxxxxx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxx; Xxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
(xxx)Xxxxxxx-X-xxxxxxxx N-benzyl xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -yl)methanon |
||
Kathinon |
(2S)-2-amino-1-fenylpropan-1-on |
||
(+)-Lysergid |
LSD, LSD-25 |
(+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin |
|
1p-LSD, 1X-XXX |
xxxxxxxxxxx kyseliny 1-xxxxxxxxx xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx-6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx xxxxxxxxx |
||
Xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
3-XXXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxxxx |
XXX, MDEA |
(2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
Methyltenamfetamin |
MDMA |
(2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
MDMB-CHMICA |
N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl xxxxx |
||
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
XXXXX; 3,4-MDPHP |
1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on |
||
2,3-Methylendioxymethkathinon |
2,3-MDMC |
1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on |
|
3,4-Methylendioxypyrovaleron |
MDPV |
1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on |
MDPK |
2-Methylethkathinon |
2-MEC |
2-(ethylamino)-1-(2-methylfenyl)propan-1-on |
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
4-Methylethkathinon |
4-MEC |
2-(ethylamino)-1-(4-methylfenyl)propan-1-on |
|
4-Methylmetkathinon |
Mefedron |
2-(methylamino)-1-(4-methylfenyl)propan-1-on |
|
5-MeO-AMT |
5-methoxy-α-methyltryptamin |
||
4-Methoxybutyr xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
3 -Xxxxxxx xxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
α-Xxxxxxxxxxxxxx butanamid xxxxxx |
XX; B-F |
2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid |
|
2-Methyl-N-ethylnorpentedron |
2-MEAP |
2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on |
|
3-Methyl-N-ethylnorpentedron |
3-MEAP |
2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on |
|
4-Methyl-N-ethylnorpentedron |
4-MEAP |
2-(ethylamino)-1-(4-methylfenyl)-pentan-1-on |
|
Methylon |
Bk-MDMA |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on |
|
2-Methylmetamfetamin |
2-MMA |
1-(2-methylfenyl)-N-methylpropan-2-amin |
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
4-Methylmetamfetamin |
4-MMA |
1-(4-methylfenyl)-N-methylpropan-2-amin |
|
2-Methylmetkathinon |
2-MMC |
2-(methylamino)-1-(2-methylfenyl)propan-1-on |
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
Methoxytenamfetamin |
MMDA |
(2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin |
|
4-MPD |
1-(4-methylfenyl)-2-methylamino-pentan-1-on |
||
Methylthienylpropamin |
MPA |
N-methyl-1-(thiofen-2-yl)propan-2-amin |
|
MT-45 |
1-cyklohexyl-4-(1,2-difenylethyl)piperazin |
||
2-Methylthioamfetamin |
2-MTA |
(2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin |
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
4-Methylthioamfetamin |
4-MTA |
(2RS)-1-[4-(methylsulfanyl)fenyllpropan-2-amin |
|
Mexedron |
4-MMC-oMe; MEX |
(3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on |
|
Naftylpyrovaleron |
Nafyron |
1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
O-2482 |
N-methyl-2-armnoindan |
N-methyl-2AI |
2,3-dihydro-N-methyl-1H-inden-2-amin |
NM-2AI |
NM-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
XX8, α-XXXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
XX9, α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-XxXX |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
Xxxxxxxxxx X |
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
∆6x(10x)-,∆6x(7)-,∆7-,∆8-,∆10-,∆9(11)-xxxxxxxxxxxxxxxxxxxx x jejich xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-51,754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx analog |
|
W-15 |
4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid |
||
W-18 |
4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid |
Včetně xxxxxxxxxxxxx xxxxxxxxxxxxxx látek, až xx xxxxxxxx výjimky, xxxxxxxxx v xxxxx xxxxxxx xx všech xxxxxxxxx, kdy xxxx xxxxxxxxxxxxx mohou xxxxxxxxx xxx xxxxxxxxxx chemického xxxxxxxx x xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xx xxxxx případech, xxx mohou xxxxxxxxx.
Xxxxxxx x. 5 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný název (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl) xxxxx]xxxxxxxxx |
||
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx butan-2-ol |
||
Bromdimethoxyfenethyl amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxx xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (THC) a xxxx stereoizomery |
např. (-)-xxxxx-Δ9-XXX |
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx x této xxxxxxx ve xxxxx xxxxxxxxx, kdy existence xxxxxxxx solí xx xxxxx.
Xxxxxxx x. 6 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx nebo obecný xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- hexahydro-2,6-methano-3-benzazocin-8-ol |
||
Pentobarbital |
kyselina 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx případech, xxx xxxxxxxxx xxxxxxxx xxxx je možná.
Příloha x. 7 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
Alprazolam |
8-chlor-6-fenyl-1-methyl-4H.[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
Amfepramon |
2-(diethylamino)-1-fenylpropan-1-on |
||
Aminorex |
5-fenyl-4,5-dihydrooxazol-2-amin |
||
Barbital |
5,5-diethylbarbiturová kyselina |
||
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethyl)-N-methylamin |
||
Benzylpiperazin |
1-benzylpiperazin |
||
Bromazepam |
7-brom-5.(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]diazepin |
||
Butobarbital |
5-butyl-5-ethylbarbiturová xxxxxxxx |
||
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- xxxxxxxxxx |
||
Xxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
Fenproprex |
(±)-1-fenyl-2-[(2-kyanethyl)amino]propan |
||
FIudiazepam |
7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2G-1,4-benzodiazepin-2-on |
||
FIurrazepam |
7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-bezodiazepin- 2-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5H)-on |
||
Chlordiazeproxid |
7-chlor-5-fenyl-2-(methylamono)-3H-1,4-benzodiazepin-4-oxid |
||
Kamazepam |
7-chIor-5-fenyl-1-methyl-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-3-yl-dimethyl xxxxxxxx |
||
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -on |
||
Mazindol |
5-(4-chlorfenyl)-2,5-dihydro-3H-imidazo[2,1-α]-isoindol-5-ol |
||
Medazepam |
7-chlor-5-fenyl-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin |
||
Mefenorex |
(±)-2-[(3-chlorpropyl)amino]-1-fenylpropan |
||
Meprobamát |
2-methyl-2-propylpropan-1,3-diyl-dikarbamát |
||
Mesokarb |
N-(fenylkarbamoyl)-3-(2-fenyl-1-methylethyl)sydnonimin |
||
Methylfenobarbital |
5-ethyl-5-fenyl-1-methylbarbiturová xxxxxxxx |
||
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxxx[1,5-α][1,4]xxxxxxxxxxxx |
||
Xxxxxxxxxxx |
5-xxxxX-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -xxxxxxxxxx-4-xx |
||
Xxxxxxxxx |
7-xxxxxx-4-xxxxx-1-(xxxx-2-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
xxxxxxX(2-xxxxxxxxx)xxxxxxxx |
||
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxx |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-α][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x této xxxxxxx ve xxxxx xxxxxxxxx, xxx existence xxxxxxxx solí xx xxxxx.
Xxxxxxx x. 8 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 8 vybraných xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
1) |
xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx obsahovat xxxxx nebo xxxx xxxxxxx látek (xxxxxxx xxxx omamných) x xxxxxxxx omamné látky |
|
a) |
v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
x) |
x xxxxxxx xxxxx být xxxxxxxxxxx xxxxx než 2,5 % |
||
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu nesmí xxxxxxxxxx x xxxxx xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx formě 0,5 xx. |
x) |
Xxxxxxxx atropin-sulfátu xxxx byt xxxxxxx 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx tabletě, xxxxxx, xxxxxx, xxxxx, popř. xxxx xxxxxx xxxxx. |
||
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx přesáhnout x jedné xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x jiné xxxxxx xxxxx 2,5 xx. |
x) |
Xxxxxxxx xxxxxxx-xxxxxxx musí xxx nejméně 1 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx. |
||
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
x) |
xxxxx přesáhnout 135 xx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, příp. x xxxx lékové xxxxx. |
||
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx než 2,5 %. |
||
Xxxxxxxxx xxxxx xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
5) |
xxxxxx |
Xxxxxxxx xxxxxxx nesmí xxxxxxxxxx 0,1 % xxxxxxx. |
|
6) |
xxxxx nebo morfin |
a) |
Množství xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
x) |
Xxxx xxxxx xxxxxxxxx jednu nebo xxxx dalších látek (xxxxxxx však xxxxxxxx). |
||
Xxxxxx xxxxx x xxxxxxxxx xxxxxxxx xxxxx xxx xxxxxx xxxxxxx xxxx x xxxxxxx xxxxxxxx, xxx xxxxxxxx xxxxxxx xxxxxx |
|||
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx nesmí xxx xxxxx než 10 %. |
x) |
Xxxxxxxx ipekakuanhového kořene xxxxx xxx xxxxx xxx 10 %. |
||
x} |
Xxxxxxxx xxxxx xxxx xxxx xxxxxxx látek (nikoliv xxxx ornamných) nesmí xxx xxxxx xxx 80%. |
||
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx nesmí xxxxxxxxxx 100 xx x jedné xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. v xxxx Xxxxxx formě. |
b) |
Mrtožství methylcelulosy x přípravku xxxx xxx xxxxxxx stejné xxxx xxxxx než xxxxxxxxx. |
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx vyšší xxx X4 nebo XX2.
Čl. XX
Xxxx xxxxxxxx xxxx xxxxxxxx v xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx při poskytování xxxxxxxxx x oblasti xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Xx. x účinností xx 1.3.2017
Čl. XX
Xxxx nařízení xxxx oznámeno x xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx a xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx předpisem x. 30/2018 Sb. x xxxxxxxxx xx 8.3.2018
Xxxxxx xxxxxxx č. 463/2013 Xx. nabyl xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx jsou xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxx xxxxx č. 243/2015 Xx.
x xxxxxxxxx xx 1.3.2017 x výjimkou xxxxxxxxx ustanovení, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, ve znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 8.3.2018
242/2018 Xx., xxxxxx se mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových látek, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx od 25.10.2018
184/2021 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., o seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2022
228/2023 Sb., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x účinností xx 1.8.2023
52/2024 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2024 x 1.1.2025
Xxxxx xxxxxxxxxxxx právních norem xxxxxx právních xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx xxxxx shora uvedeného xxxxxxxx xxxxxxxx.
1) Jednotná xxxxxx x omamných xxxxxxx, xxxxxxxxx xxx č. 47/1965 Sb., xx znění Xxxxxxxxx x xxxxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX xx xxx 25. xxxxx 2004, xxxxxx xx xxxxxxx minimální xxxxxxxxxx xxxxxxxx se znaků xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx x sankcí x xxxxxxx xxxxxxxxxxxx xxxxxxx x drogami.
Směrnice Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2017/2103 xx xxx 15. xxxxxxxxx 2017, xxxxxx xx mění xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX x cílem xxxxxxxx xx definice xxxxx xxxx xxxxxxxxxxxxx látky x zrušuje xxxxxxxxxx Xxxx 2005/387/XXX.